| Catherine M Hurt, MD | |
|
2540 East St, Concord, CA 94520-1906 | |
| (925) 682-8200 | |
| Not Available |
| Full Name | Catherine M Hurt |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 30 Years |
| Location | 2540 East St, Concord, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033132105 | NPI | - | NPPES |
| 00A546600 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A54660 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
| John Muir Medical Center - Concord Campus | Concord, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Eleven-year-old Martin Mwita, of Omaha, has made more than 300 visits to health care facilities since he was a baby. Because of sickle cell disease, he's suffered three strokes and countless other health episodes.
Following ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need, that the last remaining major AIDS drug company, Bristol-Myers Squibb (BMS) today announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.
Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.
Difficult-to-treat asthma often may have more to do with patients who do not take their medication as instructed than ineffective medication, according to researchers in Northern Ireland.
› Verified 5 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Eleven-year-old Martin Mwita, of Omaha, has made more than 300 visits to health care facilities since he was a baby. Because of sickle cell disease, he's suffered three strokes and countless other health episodes.
Following ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need, that the last remaining major AIDS drug company, Bristol-Myers Squibb (BMS) today announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.
Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.
Difficult-to-treat asthma often may have more to do with patients who do not take their medication as instructed than ineffective medication, according to researchers in Northern Ireland.
› Verified 5 days ago
| Entity Name | Cep America - Auc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568861524 PECOS PAC ID: 9537481692 Enrollment ID: O20141201002085 |
News Archive
Eleven-year-old Martin Mwita, of Omaha, has made more than 300 visits to health care facilities since he was a baby. Because of sickle cell disease, he's suffered three strokes and countless other health episodes.
Following ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need, that the last remaining major AIDS drug company, Bristol-Myers Squibb (BMS) today announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.
Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.
Difficult-to-treat asthma often may have more to do with patients who do not take their medication as instructed than ineffective medication, according to researchers in Northern Ireland.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Catherine M Hurt, MD 2100 Powell St, Suite 900, Emeryville, CA 94608-1826 Ph: (510) 350-2600 | Catherine M Hurt, MD 2540 East St, Concord, CA 94520-1906 Ph: (925) 682-8200 |
News Archive
Eleven-year-old Martin Mwita, of Omaha, has made more than 300 visits to health care facilities since he was a baby. Because of sickle cell disease, he's suffered three strokes and countless other health episodes.
Following ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need, that the last remaining major AIDS drug company, Bristol-Myers Squibb (BMS) today announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.
Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.
Difficult-to-treat asthma often may have more to do with patients who do not take their medication as instructed than ineffective medication, according to researchers in Northern Ireland.
› Verified 5 days ago
Sandra S Steffenson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2540 East St, Concord, CA 94520 Phone: 925-682-8200 | |
Dr. Ryan Todd Finlayson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2540 East St, Concord, CA 94520 Phone: 925-682-8200 | |
Bruce H Friedberg, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2540 East St, Concord, CA 94520 Phone: 925-682-8200 | |
Dr. Ingrid T. Lim, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2540 East St, Concord, CA 94520 Phone: 415-682-8200 | |
Jennifer Grayzar, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2540 East St, Concord, CA 94520 Phone: 925-682-8200 | |
Hartwell N Lin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2540 East St, Concord, CA 94520 Phone: 925-682-8200 |